Acadia Pharmaceuticals reported $0 in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
ALKERMES ALKS:US USD 293.9M 633K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Aptinyx Inc APTX:US USD 24.71M 211K
Biogen BIIB:US USD 6.28B 998M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Bristol Myers Squibb BMY:US USD 39.1B 2.96B
Cytokinetics CYTK:US USD 610.73M 411.31M
Eisai 4523:JP JPY 94.91B 8M
Eli Lilly And LLY:US USD 15.89B 925.4M
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
Marinus Pharmaceuticals MRNS:US USD 70.78M 430K
Moderna Inc MRNA:US USD 1.15B 384M
Neurocrine Biosciences NBIX:US USD 169.2M 200K
Ptc Therapeutics PTCT:US USD 1.06B 145.39M
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M
YTE INCY:US USD 33.59M 605K